Abstract 1300: Evaluating the relative bioavailability of a new formulation of navitoclax (ABT-263) in both cancer patients and healthy volunteers

Jianning Yang, Hao Xiong, Andrew Krivoshik, Kyle Holen, Rajendra Pradhan, Yi-Lin Chiu, Adel Nada, Anthony Tolcher, Walid Awni, Rod Humerickhouse
  • Cancer Research, April 2011, American Association for Cancer Research (AACR)
  • DOI: 10.1158/1538-7445.am2011-1300
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Allison M Kitten